// STATE LEGISLATION TRACKER

Rhode Island HB 8245 — AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Rhode Island
Bill: HB 8245
Filed: 2026-03-06
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Based only on the title and subject, this appears to be an insurance bill about accident and sickness insurance policies. It does not show a direct connection to compounded peptides, off-label prescribing, telehealth, naturopathic or NP scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No clear peptide-specific restriction or access expansion is visible from the title
This appears focused on insurance policy rules, not prescribing or compounding
No direct telehealth, NP, naturopathic, or pharmacy scope issue is apparent

What to Watch For

Note Bill text was not available here, so peptide impact cannot be assessed beyond the title and subject.

Note If later text affects insurance coverage for drugs or biologics, cost impact could become relevant.

Note Monitor for amendments that mention compounded drugs, prior authorization, or coverage exclusions.

Where the Bill Stands

The provided source did not show a latest action or usable bill text, so the bill's current process status is unknown.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws